Skip to main content
Article
Emerging use of senolytics and senomorphics against aging and chronic diseases
Medicinal Research Reviews
  • Jan Martel, Chang Gung University
  • David M. Ojcius, University of the Pacific, California
  • Cheng Yeu Wu, Chang Gung University
  • Hsin Hsin Peng, Chang Gung University
  • Laurent Voisin, Radiothérapie Moléculaire
  • Jean Luc Perfettini, University of the Pacific
  • Yun Fei Ko, Chang Gung Memorial Hospital
  • John D. Young, Chang Gung University
ORCiD
David M. Ojcius: 0000-0003-1461-4495
Department
Biomedical Sciences
Document Type
Article
DOI
10.1002/med.21702
Publication Date
1-1-2020
Disciplines
Abstract

© 2020 Wiley Periodicals LLC Senescence is a state of cell cycle arrest that plays an important role in embryogenesis, wound healing and protection against cancer. Senescent cells also accumulate during aging and contribute to the development of age-related disorders and chronic diseases, such as atherosclerosis, type 2 diabetes, osteoarthritis, idiopathic pulmonary fibrosis, and liver disease. Molecules that induce apoptosis of senescent cells, such as dasatinib, quercetin, and fisetin, produce health benefits and extend lifespan in animal models. We describe here the mechanism of action of senolytics and senomorphics, many of which are derived from plants and fungi. We also discuss the possibility of using such compounds to delay aging and treat chronic diseases in humans.

Citation Information
Jan Martel, David M. Ojcius, Cheng Yeu Wu, Hsin Hsin Peng, et al.. "Emerging use of senolytics and senomorphics against aging and chronic diseases" Medicinal Research Reviews (2020) ISSN: 01986325
Available at: http://works.bepress.com/david-ojcius/300/